Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy

AIMS: Exogenous atrial natriuretic peptide (ANP) may be a logical treatment for heart failure (HF) patients with ANP deficiency. Lower ANP concentrations may result from HF with preserved ejection fraction (HFpEF), which also results in lower brain natriuretic peptide levels in HFpEF relative to HF...

Full description

Saved in:
Bibliographic Details
Published in:ESC Heart Fail
Main Authors: Matsumoto, Shingo, Nakazawa, Gaku, Ohno, Yohei, Ishihara, Mai, Sakai, Katsuaki, Nakamura, Norihito, Murakami, Tsutomu, Natsumeda, Makoto, Kabuki, Takayuki, Shibata, Atsushi, Kida, Keisuke, Konishi, Masaaki, Ishii, Shunsuke, Ikeda, Takanori, Ikari, Yuji
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Original Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754892/
https://ncbi.nlm.nih.gov/pubmed/33037750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13042
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items